About: Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.46 (+2.22%)
CMBASXCambium Bio Ltd
Cambium Bio Ltd share price
CMB price activity
Último preço
$ 0,460
Variação (24h)
0,01 AUD (2,22%)
Volume
500
Volume (média 4 sem.)
-
Abertura
$ 0,46
Variação do dia
$ 0,46 - $ 0,46
Fechamento anterior
$ 0,45
Último negócio
04 Sep, 12:01 am GMT+0
Atrasado
04 Sep, 12:01 am GMT+0
CMB price performance
Atrasado
04 Sep, 12:01 am GMT+0
quote.marketSignals